Coumarin-purine ribofuranoside conjugates as new agents against hepatitis c virus

Journal of Medicinal Chemistry

Volumn 54, Issue 7, 2011, Pages 2114-2126

  Hwu, Jih Ru ^a,b   Lin, Shu Yu ^a   Tsay, Shwu Chen ^a   De Clercq, Erik ^c   Leyssen, Pieter ^c   Neyts, Johan ^c  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COUMARIN; COUMARIN NEBULARINE CONJUGATE; NEBULARINE; PEGINTERFERON ALPHA; RIBAVIRIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG CONJUGATION; DRUG STRUCTURE; DRUG SYNTHESIS; HEPATITIS C; HEPATITIS C VIRUS; HYDROPHILICITY; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; COUMARINS; DRUG DISCOVERY; FURANS; HEPACIVIRUS; HUMANS; HYDROXIDES; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PURINE NUCLEOSIDES; RIBONUCLEOSIDES; SOLUBILITY; VIRUS REPLICATION;

EID: 79953776648     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm101337v     Document Type: Article

References (43)

1. For a recent review, see the following: Craxe, A.; Laffi, G.; Zignego, A. L. Hepatitis C Virus (HCV) Infection: A Systemic Disease Mol. Aspects Med. 2008, 29, 85-95
2. Choo, Q.-L.; Kuo, G.; Weiner, A. J.; Overby, L. R.; Bradley, D. W.; Houghton, M. Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome Science 1989, 244, 359-362 (Pubitemid 19117877)
3. For a review, see the following: Hayashi, N.; Takehara, T. Antiviral Therapy for Chronic Hepatitis C: Past, Present, and Future J. Gastroenterol. 2006, 41, 17-27
4. For recent reviews, see the following: Manns, M. P.; Foster, G. R.; Rockstroh, J. K.; Zeuzem, S.; Zoulim, F.; Houghton, M. The Way Forward in HCV Treatment: Finding the Right Path Nat. Rev. Drug Discovery 2007, 6, 991-1000 (Pubitemid 350201789)
5. De Clercq, E. The Design of Drugs for HIV and HCV Nat. Rev. Drug Discovery 2007, 6, 1001-1018 (Pubitemid 350213865)
6. Belon, C. A.; Frick, D. N. Helicase Inhibitors as Specifically Targeted Antiviral Therapy for Hepatitis C Future Virol. 2009, 4, 277-293
7. For recent representative work, see the following: Chen, C.-S.; Chiou, C.-T.; Chen, G. S.; Chen, S.-C.; Hu, C.-Y.; Chi, W.-K.; Chu, Y.-D.; Hwang, L.-H.; Chen, P.-J.; Chen, D.-S.; Liaw, S.-H.; Chern, J.-W. Structure-Based Discovery of Triphenylmethane Derivatives as Inhibitors of Hepatitis C Virus Helicase J. Med. Chem. 2009, 52, 2716-2723
8. Manfroni, G.; Paeshuyse, J.; Massari, S.; Zanoli, S.; Gatto, B.; Maga, G.; Tabarrini, O.; Cecchetti, V.; Fravolini, A.; Neyts, J. Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor J. Med. Chem. 2009, 52, 3354-3365
9. Di Francesco, M. E.; Dessole, G.; Nizi, E.; Pace, P.; Koch, U.; Fiore, F.; Pesci, S.; Di Muzio, J.; Monteagudo, E.; Rowley, M.; Summa, V. Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1,3-thiazole as a P4 Carbamate Replacement J. Med. Chem. 2009, 52, 7014-7028
10. Popovici-Muller, J.; Shipps, G. W., Jr.; Rosner, K. E.; Deng, Y.; Wang, T.; Curran, P. J.; Brown, M. A.; Siddiqui, M. A.; Cooper, A. B.; Duca, J.; Cable, M.; Girijavallabhan, V. Pyrazolo[1,5- a ]pyrimidine-Based Inhibitors of HCV Polymerase Bioorg. Med. Chem. Lett. 2009, 19, 6331-6336
11. Goulet, S.; Poupart, M.-A.; Gillard, J.; Poirier, M.; Kukolj, G.; Beaulieu, P. L. Discovery of Benzimidazole-diamide Finger Loop (Thumb Pocket I) Allosteric Inhibitors of HCV NS5B Polymerase: Implementing Parallel Synthesis for Rapid Linker Optimization Bioorg. Med. Chem. Lett. 2010, 20, 196-200
12. Farghaly, T. A.; Hafez, N. A. A.; Ragab, E. A.; Awad, H. M.; Abdalla, M. M. Synthesis, Anti-HCV, Antioxidant, and Peroxynitrite Inhibitory Activity of Fused Benzosuberone Derivatives Eur. J. Med. Chem. 2010, 45, 492-500
13. Koh, Y.-h.; Shim, J. H.; Wu, J. Z.; Zhong, W.; Hong, Z.; Girardet, J.-L. Design, Synthesis, and Antiviral Activity of Adenosine 5′-Phosphonate Analogues as Chain Terminators against Hepatitis C Virus J. Med. Chem. 2005, 48, 2867-2875 (Pubitemid 40548101)
14. Perrone, P.; Daverio, F.; Valente, R.; Rajyaguru, S.; Martin, J. A.; Lévsque, V.; Le Pogam, S.; Najera, I.; Klumpp, K.; Smith, D. B.; McGuigan, C. First Example of Phosphoramidate Approach Applied to a 4′-Substituted Purine Nucleoside (4′-Azidoadenosine): Conversion of an Inactive Nucleoside to a Submicromolar Compound versus Hepatitis C Virus J. Med. Chem. 2007, 50, 5463-5470 (Pubitemid 350057856)
15. Ding, Y.; Girardet, J.-L.; Hong, Z.; Lai, V. C. H.; An, H.; Koh, Y.-h.; Shaw, S. Z.; Zhong, W. Synthesis of 9-(2-β- C -Methyl-β- d -ribofuranosyl)-6-substituted Purine Derivatives as Inhibitors of HCV RNA Replication Bioorg. Med. Chem. Lett. 2005, 15, 709-713 (Pubitemid 40143152)
16. Ikejiri, M.; Ohshima, T.; Kato, K.; Toyama, M.; Murata, T.; Shimotohno, K.; Maruyama, T. 5′- O -Masked 2′-Deoxyadenosine Analogues as Lead Compounds for Hepatitis C Virus (HCV) Therapeutic Agents Bioorg. Med. Chem. 2007, 15, 6882-6892 (Pubitemid 47470047)
17. Hocek, M.; Nau , P.; Pohl, R.; Votruba, I.; Furman, P. A.; Tharnish, P. M.; Otto, M. J. Cytostatic 6-Arylpurine Nucleosides. 6. SAR in Anti-HCV and Cytostatic Activity of Extended Series of 6-Hetarylpurine Ribonucleosides J. Med. Chem. 2005, 48, 5869-5873 (Pubitemid 41298356)
18. Wan, J.; Xia, Y.; Liu, Y.; Wang, M.; Rocchi, P.; Yao, J.; Qu, F.; Neyts, J.; Iovanna, J. L.; Peng, L. Discovery of Novel Arylethynyltriazole Ribonucleosides with Selective and Effective Antiviral and Antiproliferative Activity J. Med. Chem. 2009, 52, 1144-1155
19. Kim, H.-J.; Sharon, A.; Bal, C.; Wang, J.; Allu, M.; Huang, Z.; Murray, M. G.; Bassit, L.; Schinazi, R. F.; Korba, B.; Chu, C. K. Synthesis and Anti-Hepatitis B Virus and Anti-Hepatitis C Virus Activities of 7-Deazaneplanocin A Analogues in Vitro J. Med. Chem. 2009, 52, 206-213
20. Sidewell, R. W.; Huffman, J. H.; Khare, G. P.; Allen, L. B.; Witkowski, J. T.; Robins, R. K. Broad-Spectrum Antiviral Activity of Virazole: 1-β- d -Ribofuranosyl-1,2,4-triazole-3-carboxamide Science 1972, 177, 705-706
21. Crotty, S.; Maag, D.; Arnold, J. J; Zhong, W.; Lau, J. Y. N.; Hong, Z.; Andino, R.; Cameron, C. E. The Broad-Spectrum Antiviral Ribonucleoside Ribavirin Is an RNA Virus Mutagen Nat. Med. 2000, 6, 1375-1379 (Pubitemid 32001022)
22. Bosch, M. E.; Sánchez, A. J. R.; Rojas, F. S.; Ojeda, C. B. Ribavirin: Analytical Determinations Since the Origin until Today J. Pharm. Biomed. Anal. 2007, 45, 185-193 (Pubitemid 47513418)
23. Xu, B.; Zhu, Q.; Cho, H.-J.; Fathi, R.; Yang, Z.; Sandrasagra, A.; Liu, Y. 3,4-Disubstituted Coumarin and Quinolone Compounds. U.S. Patent 0,223,783 A1, 2006.
24. Wu, J.; Yang, Z.; Fathi, R.; Zhu, Q. 4-Thio Coumarins. U.S. Patent 0,180,950 A1, 2004.
25. Hsieh, H.-P.; Hsu, T.-A.; Yeh, J.-Y.; Horng, J.-T.; Shih, S.-R.; Chang, S.-Y.; Chao, Y.-S. Coumarin Compounds and Their Use for Treating Viral Infection. U.S. Patent 0,312,406 A1, 2009.
26. Kaushik-Basu, N.; Bopda-Waffo, A.; Talele, T. T.; Basu, A.; Costa, P. R. R.; da Silva, A. J. M.; Sarafianos, S. G.; No l, F. Identification and Characterization of Coumestans as Novel HCV NS5B Polymerase Inhibitors Nucleic Acids Res. 2008, 36, 1482-1496 (Pubitemid 351426102)
27. Hwu, J. R.; Singha, R.; Hong, S. C.; Chang, Y. H.; Das, A. R.; Vliegen, I.; De Clercq, E.; Neyts, J. Synthesis of New Benzimidazole-Coumarin Conjugates as Anti-Hepatitis C Virus Agents Antiviral Res. 2008, 77, 157-162
28. Neyts, J.; De Clercq, E.; Singha, R.; Chang, Y. H.; Das, A. R.; Chakraborty, S. K.; Hong, S. C.; Tsay, S.-C.; Hsu, M.-H.; Hwu, J. R. Structure-activity Relationship of New Anti-Hepatitis C Virus Agents: Heterobicycle Coumarin Conjugates J. Med. Chem. 2009, 52, 1486-1490
29. For a review, see the following: Viegas-Junior, C.; Danuello, A.; Bolzani, V. D. S.; Barreiro, E. J.; Fraga, C. A. M. Molecular Hybridization: A Useful Tool in the Design of New Drug Prototypes Curr. Med. Chem. 2007, 14, 1829-1852 (Pubitemid 47163402)
30. Blackburn, G. M.; Gait, M. J.; Loakes, D.; Williams, D. M. In Nucleic Acids in Chemistry and Biology, 3 rd ed.; The Royal Society of Chemistry: Cambridge, U.K., 2006; Chapter 3.
31. Vorbr ggen, H.; Krolikiewicz, K.; Bennua, B. Nucleoside Syntheses, XXII Nucleoside Synthesis with Trimethylsilyl Triflate and Perchlorate as Catalysts Chem. Ber. 1981, 114, 1234-1255
32. Silverstein, R. M.; Webster, F. X.; Kiemle, D. J. Spectrometric Identification of Organic Compounds, 7 th ed.; John Wiley & Sons: New York, 2005; p 98.
33. Secrist, J. A., III; Shortnacy-Fowler, A.; Bennett, L. L., Jr.; Montgomery, J. A. Synthesis and Biologic Evaluation of 8-Substituted Derivatives of Nebularine (9-β- d -Ribofuranosylpurine) Nucleosides Nucleotides 1994, 13, 1017-1029 (Pubitemid 24160981)
34. Ikehara, M.; Uesugi, S.; Yoshida, K. Studies on the Conformation of Purine Nucleosides and Their 5′-Phosphates Biochemistry 1972, 11, 830-836
35. 31P} Fast Fourier Transform Nuclear Magnetic Resonance Methods and Conformational Energy Calculations J. Am. Chem. Soc. 1974, 96, 7337-7348
36. Holmes, R. E.; Robins, R. K. Purine Nucleosides. VII. Direct Bromination of Adenosine, Deoxyadenosine, Guanosine, and Related Purine Nucleosides J. Am. Chem. Soc. 1964, 86, 1242-1245
37. Ikehara, M.; Kaneko, M. Studies of Nucleosides and Nucleotides - XLI: Purine Cyclonucleosides - 8 Selective Sulfonylation of 8-Bromoadenosine Derivatives and an Alternate Synthesis of 8,2′-And 8,3′- S -Cyclonucleosides Tetrahedron 1970, 26, 4251-4259
38. Thomas, G. In Medicinal Chemistry. An Introduction, 2 nd ed.; John Wiley & Sons: West Sussex, England, 2007; Chapter 2.
39. Bookser, B. C.; Ugarkar, B. G.; Matelich, M. C.; Lemus, R. H.; Allan, M; Tsuchiya, M.; Nakane, M.; Nagahisa, A.; Wiesner, J. B.; Erion, M. D. Adenosine Kinase Inhibitors. 6. Synthesis, Water Solubility, and Antinociceptive Activity of 5-Phenyl-7-(5-deoxy-β- d -ribofuranosyl)pyrrolo[2,3- d ]pyrimidines Substituted at C4 with Glycinamides and Related Compounds J. Med. Chem. 2005, 48, 7808-7820 (Pubitemid 41698820)
40. Lohmann, V.; Körner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R. Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line Science 1999, 285, 110-113 (Pubitemid 29307577)
41. Paeshuyse, J.; Kaul, A.; De Clercq, E.; Rosenwirth, B.; Dumont, J.-M.; Scalfaro, P.; Bartenschlager, R.; Neyts, J. The Non-Immunosuppressive Cyclosporin DEBIO-025 Is a Potent Inhibitor of Hepatitis C Virus Replication in Vitro Hepatology 2006, 43, 761-770
42. Wilde, R. G.; Billheimer, J. T.; Germain, S. J.; Gillies, P. J.; Higley, C. A.; Kezar, H. S., III; Maduskuie, T. P.; Shimshick, E. S.; Wexler, R. R. Acyl CoA: Cholesterol Acyltransferase (ACAT) Inhibitors: Ureas Bearing Heterocyclic Groups Bioisosteric for an Imidazole Bioorg. Med. Chem. Lett. 1995, 5, 167-172
43. Kaye, P. T.; Musa, M. A. A Convenient and Improved Baylis-Hillman Synthesis of 3-Substututed 2 H -1-Benzopyran-2-ones Synthesis 2002, 2701-2706 (Pubitemid 36034429)